NEW ORLEANS—The first generation of drug-eluting stents has come under fire in recent months for inappropriate use in some patients with stable coronary artery disease and for possibly promoting late-event thrombosis. But stents remain essential tools for cardiologists treating patients with a variety of coronary problems, and researchers and manufacturers continue to design and test new versions, with the aim of improving outcomes while diminishing adverse events.
Mitka M. New Drug-Eluting Stents Under Study. JAMA. 2007;297(19):2064–2067. doi:10.1001/jama.297.19.2064
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: